Health officials in New Hampshire said despite a slight uptick in COVID-19 cases recently, the focus will be on the various respiratory viruses circulating this fall. The number of hospitalizations is also increasing,” said state epidemiologist Dr. Benjamin Chan. Covid-19 is still prevalent in Granite State, although the numbers are lower than before. “The number of deaths from COVID-19 is averaging less than one person per day,” Chan said. In July, an average of five people were admitted to the hospital for COVID-19 treatment each day in New Hampshire. As of Friday, that number is 10 to 15 per day. “Certainly, the numbers are still low. I don’t see this as a surge,” Chan said. Although no new coronavirus cases have been reported as during the pandemic, testing will allow the province to track rising levels of the new coronavirus from December 2022 onwards. “In the wastewater, we usually see signs of COVID-19, but there are signs of other diseases,” said engineer Fred McNeil. The University of New Hampshire and the State Department of Health and Human Services participated in a formal sampling program. “We sample the wastewater twice a week, which he does, and the state takes that and uses it as an indicator of how COVID-19 is doing in the pandemic,” McNeil said. “Take it to the lab and test it to get some idea of the level of virus detected in the wastewater,” Chan said. Chan said the focus is shifting away from just the novel coronavirus, and that as we enter autumn, or “respiratory virus season,” as Chan calls it, people need to be more vigilant about disease prevention. Ways to prevent illness also include receiving the latest novel coronavirus information – 19 vaccines to be released in the next few months, the latest flu vaccines on sale now, people over 60 A new RSV vaccine for children and a new RSV monoclonal antibody therapy for neonates and infants. Chan said people should talk to their health care providers and ask what is best for them.
Health officials in New Hampshire said despite a slight uptick in COVID-19 cases recently, attention will be focused on the various respiratory viruses circulating this fall.
“What’s interesting is that there has been a very slight increase in hospitalizations in the last month,” said state epidemiologist Dr. Benjamin Chan.
Covid-19 is still rampant in Granite State, although fewer than we once saw.
“We are averaging less than one death a day from COVID-19,” Chan said.
In July, an average of five people a day were hospitalized for COVID-19 in New Hampshire. As of Friday, that number is 10 to 15 per day.
“It’s certainly still a small number. I wouldn’t call it a surge,” Chan said.
Although COVID-19 cases have not been reported as during the pandemic, after December 2022, the state will track rising COVID-19 levels by: I am able to do it. Wastewater tested at 14 different facilities.
>> See the latest wastewater data
Fred McNeil, chief engineer for the city of Manchester’s environmental protection department, said: “We usually see signs of COVID-19 in wastewater, but we also see signs of other diseases.”
McNeill said it has partnered with the University of New Hampshire and the state Department of Health and Human Services to participate in a formal sampling program.
“We sample the wastewater twice a week. The state takes that and uses it as an indicator of how the coronavirus is doing in the pandemic,” McNeil said.
“Take it to the lab and test it to get some idea of the level of virus you find in the wastewater,” Chan says.
But Chan said the focus is shifting away from just COVID-19, and that as we enter autumn, or “respiratory virus season,” as Chan calls it, people need to be more vigilant about disease prevention. Ta.
Ways to prevent illness include the latest novel coronavirus vaccine coming out in the next few months, the latest flu vaccine now on sale, the new RSV vaccine for people over 60, and the new RSV vaccine for newborns and the elderly. and monoclonal antibody therapy. infant.
Chan said people should talk to their health care providers and ask what is best for them.